Search

everythinglearnresearchcommunity

for

Search:↓

Consider benefits and risks of new alopecia treatments for safety.

The Brazilian Society of Dermatology agrees that oral isotretinoin is effective for acne and other skin conditions, and it's safe when monitored, but more research is needed on dosing and duration.

Interferons are effective for some skin conditions and cancers, but can have side effects and need more research for optimal use.

The document concludes that stopping shaving or removing affected hair can alleviate Pseudofolliculitis barbae (PFB).

Nurses are crucial in managing chemotherapy side effects for ovarian cancer patients to improve their quality of life.

JAK inhibitors may soon be a safe and effective treatment for alopecia areata.

The document says that treating the root cause of hair follicle damage is crucial to prevent permanent hair loss, and treatment options vary.

There is no standard treatment for the rare Cronkhite–Canada syndrome, which can be fatal and lead to cancer.

Tailor treatments for vitiligo to patient needs for best results.

The document concludes that various treatments, including laser therapy, are effective for managing pseudofolliculitis barbae, especially in darker skin types.

The enzymes 5α-reductase and 3α/β-hydroxysteroid oxidoreductase help create brain-active substances from progesterone and testosterone, which could be used for treatment, but more research is needed to ensure their safety and effectiveness.

Calcipotriol plus betamethasone with microneedling works better than tacrolimus for treating vitiligo.

EGFR inhibitors can cause various skin issues during cancer treatment, and managing these is important for patient care.

Certain immune cells contribute to severe hair loss in chronic alopecia areata, with Th17 cells possibly having a bigger impact than cytotoxic T cells.

Laser-assisted drug delivery has shown improved treatment outcomes for skin conditions and has potential to reduce side effects and treatment time.

The document concludes that oral finasteride and topical minoxidil are effective for genetic hair loss, while other treatments for different types of hair loss show promise but need more research.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

Most children with CNS tumors on targeted therapy had skin reactions, which were generally treatable without stopping the therapy.

Lichen Planopilaris in teens is rare, often misdiagnosed, and responds well to steroids.

Alopecia Areata is an autoimmune hair loss condition that needs more research for better treatments.

New treatments for skin conditions related to the sebaceous gland are being developed based on current research.

Propranolol is effective and safe for treating infantile hemangioma, but more research is needed for dosing and monitoring guidelines.

The document concludes that there are no reliable treatments for frontal fibrosing alopecia, with only temporary benefits from current options.

Birth control pills can help reduce mild to moderate acne in women.

Platelet-Rich Plasma (PRP) could potentially help regrow hair in people with Alopecia Areata, but more research is needed to confirm its effectiveness.

The erbium-glass laser effectively promotes hair regrowth in alopecia areata.

Both emollients effectively reduced itching and improved skin moisture in xerotic eczema.

Latanoprost works better for hair growth, and combining it with betamethasone valerate is most effective.

Start acne treatment early to prevent scarring, consider antibiotic resistance, use maintenance therapy, and manage side effects carefully.

Skin doctors should recognize and treat conditions like hair-pulling and skin-picking early, often using therapy and medication, to help 50-70% of patients.